75
Participants
Start Date
July 23, 2019
Primary Completion Date
April 22, 2022
Study Completion Date
April 22, 2022
mNavigator
Allied health providers at BMC will use mNavigator to facilitate compliance with protocol-driven treatment and reduce patient abandonment for patients diagnosed with Burkitt lymphoma, Diffuse large B-cell lymphoma or retinoblastoma.
Bugando Medical Centre, Mwanza
Lead Sponsor
National Cancer Institute (NCI)
NIH
Duke University
OTHER